Adapting Acceptance and Commitment Therapy for Stroke Survivors With Aphasia
Adapting Acceptance and Mindfulness-based Behavior Therapy for Stroke Survivors With Aphasia to Improve Communication Success, Post-stroke Adaptation, and Quality of Life
2 other identifiers
interventional
20
1 country
1
Brief Summary
The proposed study is a Stage I successive cohort trial intended to adapt Acceptance and Commitment Therapy (ACT) to meet the specific needs of stroke survivors with aphasia ("ACT for Aphasia"). It will do so by incorporating communication supports and compensatory speech-language treatment. The goal of developing this integrated treatment is to improve successful communication participation, psychosocial adjustment, and quality of life for stroke survivors with aphasia. In the first phase of the project, the investigators will create a treatment manual with input from a stakeholder advisory board consisting of caregivers and stroke survivors with aphasia. The investigators will then recruit an initial cohort of five stroke survivors with aphasia to undergo the initial version of the treatment based and provide feedback. This will aid revision of the manual, which the investigators will then evaluate using a second cohort of 16 stroke survivors with aphasia. The investigators predict that ACT for Aphasia will be acceptable and feasible based on measures of participant satisfaction and treatment adherence. The investigators will also measure pre- to post-treatment changes in psychological distress, functional disability, quality of life, and communication participation and functioning to establish preliminary effect size estimates for this intervention, in preparation for a subsequent Stage II efficacy trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Nov 2021
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2021
CompletedFirst Posted
Study publicly available on registry
July 30, 2021
CompletedStudy Start
First participant enrolled
November 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2024
CompletedResults Posted
Study results publicly available
April 25, 2025
CompletedApril 25, 2025
April 1, 2025
2.2 years
July 20, 2021
January 20, 2025
April 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean Scores on the Client Satisfaction Questionnaire - 8
The Client Satisfaction Questionnaire - 8 (CSQ-8) is a brief questionnaire demonstrated to provide "efficient, sensitive, and reasonably comprehensive" measures of patient satisfaction. It has 8 questions rated on a 4-point scale (summed scores range from 8 to 32). High scores indicate high satisfaction and low scores indicate low satisfaction. The CSQ-8 is the primary measure which will determine acceptability of the proposed pilot intervention.
Post-treatment (within one week of completing the treatment phase)
Secondary Outcomes (7)
Mean Scores on the Acceptance and Action Questionnaire II
Baseline and Post-Treatment (within one week of completing the treatment phase)
Mean Scores on the Acceptance and Action Questionnaire - Acquired Brain Injury
Baseline and Post-Treatment (within one week of completing the treatment phase)
Mean Scores on the Kessler K6 Non-specific Distress Scale
Baseline and Post-Treatment (within one week of completing the treatment phase)
Mean Scores on the Stroke and Aphasia Quality of Life Scale
Baseline and Post-Treatment (within one week of completing the treatment phase)
Mean Scores on the Aphasia Outcome Measure
Baseline and Post-Treatment (within one week of completing the treatment phase)
- +2 more secondary outcomes
Study Arms (1)
Acceptance and Commitment Therapy adapted for aphasia
OTHERThere is only a single study arm, in which the adapted intervention will be developed using a successive cohort design.
Interventions
The intervention will consist of Acceptance and Commitment Therapy modified to meet the needs of stroke survivors with aphasia, combined with communication strategy training.
Eligibility Criteria
You may qualify if:
- Participants will be age 18 or older.
- Participants will have an existing diagnosis of aphasia subsequent to left hemisphere stroke.
You may not qualify if:
- Participants with a history of other acquired or progressive neurological disease.
- Participants whose mean modality t-score falls below 40 on the spoken language comprehension subdomain of the Comprehensive Aphasia Test.
- Participants with semantic memory impairments as determined by the cutoff of the semantic memory component of the Comprehensive Aphasia Test.
- Participants with unmanaged drug /alcohol dependence.
- Participants with severe diagnose.d mood or behavioral disorders that require specialized mental health interventions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Language Rehab and Cognition Lab, Department of Communication Sciences and Disorders, School of Health and Rehabilitation Sciences, University of Pittsburgh
Pittsburgh, Pennsylvania, 15260, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- William Evans
- Organization
- University of Pittsburgh
Study Officials
- PRINCIPAL INVESTIGATOR
William Evans, PhD
University of Pittsburgh
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 20, 2021
First Posted
July 30, 2021
Study Start
November 2, 2021
Primary Completion
January 22, 2024
Study Completion
January 22, 2024
Last Updated
April 25, 2025
Results First Posted
April 25, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Data will be shared at the time of study publication without planned end to access.
- Access Criteria
- Anyone who wishes to access the data.
De-identified data from this research will be shared with the wider scientific community in a timely fashion, concurrent with publication with no planned end date. Materials shared in this fashion will consist of all de-identified participant assessment and outcome data, acceptability and feasibility measures, the study protocol, statistical analysis plan, and treatment manual. These materials will be shared via the National Institute of Child Health and Human Development Data and Specimen Hub (NICHD DASH) and made additionally available by sharing the developed treatment manual and other supporting information on Dr. Evans' lab website.